ILT3 polypeptides and uses thereof
    1.
    发明授权
    ILT3 polypeptides and uses thereof 有权
    ILT3多肽及其用途

    公开(公告)号:US09150635B2

    公开(公告)日:2015-10-06

    申请号:US13480421

    申请日:2012-05-24

    IPC分类号: A61K38/16 C07K14/705

    CPC分类号: C07K14/70503 C07K2319/30

    摘要: This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention.

    摘要翻译: 本发明提供了包含ILT3的全部或部分细胞外结构域的第一多肽,其中多肽是水溶性的并且不包含免疫球蛋白的Fc部分。 本发明还提供了第二多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地附着于(ii)免疫球蛋白的Fc部分,其中所述免疫球蛋白的Fc部分包含功能增强突变,并且其中 该多肽是水溶性的。 本发明还提供了第三多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地固定于(ii)跨膜结构域。 本发明还提供了使用本发明的多肽的相关核酸,表达载体,宿主载体系统,组合物和制品以及治疗和预防方法。

    Direct conversion receiver radio frequency integrated circuit
    2.
    发明申请
    Direct conversion receiver radio frequency integrated circuit 审中-公开
    直接转换接收机射频集成电路

    公开(公告)号:US20060068746A1

    公开(公告)日:2006-03-30

    申请号:US10956778

    申请日:2004-09-30

    IPC分类号: H04B1/26 H04B15/00

    CPC分类号: H04B1/30

    摘要: An integrated circuit includes an RF receiver has a direct-conversion down-converter and demodulator architecture with an integrated low noise amplifier (LNA) for operation in a frequency band of interest (cellular) and provisions for an off-chip LNA for operation in a second (higher) frequency band of interest (such as PCS). A baseband processor includes high-dynamic variable gain amplifiers and 7th-order elliptic low-pass filters. The IC also includes a 4 GHz PLL frequency synthesizer and a three wire series interface to external digital baseband circuits, such as a digital signal processor.

    摘要翻译: 一种集成电路包括RF接收机,其具有用于在感兴趣的频带(蜂窝)中操作的集成低噪声放大器(LNA)的直接转换下变频器和解调器架构,并且为片外LNA提供操作 感兴趣的第二(更高)频带(例如PCS)。 基带处理器包括高动态可变增益放大器和7阶椭圆低通滤波器。 该IC还包括一个4 GHz PLL频率合成器和一个三线串行接口,用于外部数字基带电路,如数字信号处理器。

    ITL3 polypeptides and uses thereof
    3.
    发明授权
    ITL3 polypeptides and uses thereof 有权
    ITL3多肽及其用途

    公开(公告)号:US08207110B2

    公开(公告)日:2012-06-26

    申请号:US11661877

    申请日:2005-09-01

    IPC分类号: A61K38/00

    CPC分类号: C07K14/70503 C07K2319/30

    摘要: This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention.

    摘要翻译: 本发明提供了包含ILT3的全部或部分细胞外结构域的第一多肽,其中多肽是水溶性的并且不包含免疫球蛋白的Fc部分。 本发明还提供了第二多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地附着于(ii)免疫球蛋白的Fc部分,其中所述免疫球蛋白的Fc部分包含功能增强突变,并且其中 该多肽是水溶性的。 本发明还提供了第三多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地固定于(ii)跨膜结构域。 本发明还提供了使用本发明的多肽的相关核酸,表达载体,宿主载体系统,组合物和制品以及治疗和预防方法。

    RF AND HIGH-SPEED DATA CABLE
    4.
    发明申请
    RF AND HIGH-SPEED DATA CABLE 审中-公开
    射频和高速数据线

    公开(公告)号:US20130265117A1

    公开(公告)日:2013-10-10

    申请号:US13441625

    申请日:2012-04-06

    IPC分类号: H01P5/10

    CPC分类号: H04B15/04 H04B1/40

    摘要: A cable is disclosed for transmitting high speed digital baseband signals together with analog RF signals between first and second components. The RF signals may be transmitted between an antenna in the first component and an RF transceiver in the second component at operating frequencies such as for example 70 MHz to 6 GHz. In order to reduce cross-talk between the digital and analog lines, the analog signal may be carried over a line including a pair of wires such as a differential signal pair. The pair of wires carrying the analog signal may include baluns at either end to enable delivery over the pair of wires. The baluns may be wideband baluns to support communication over the full range of operating frequencies. In order to further reduce cross-talk, the digital and/or analog lines may be encased within an EMI-absorbing jacket made of extruded ferrite as one example.

    摘要翻译: 公开了一种用于在第一和第二组件之间传输高速数字基带信号以及模拟RF信号的电缆。 RF信号可以在工作频率例如70MHz至6GHz的范围内在第一组件中的天线和第二组件中的RF收发器之间传输。 为了减少数字和模拟线路之间的串扰,模拟信号可以通过包括诸如差分信号对的一对导线的线路传送。 承载模拟信号的一对导线可以包括在任一端的不平衡变换器,以使得能够在一对导线上传送。 不平衡变压器可以是宽带巴伦,以支持在整个工作频率范围内的通信。 为了进一步减少串扰,可以将数字和/或模拟线路封装在由挤出铁氧体制成的EMI吸收套管内作为一个示例。

    ILT3 Polypeptides and Uses Thereof
    5.
    发明申请
    ILT3 Polypeptides and Uses Thereof 有权
    ILT3多肽及其用途

    公开(公告)号:US20120321623A1

    公开(公告)日:2012-12-20

    申请号:US13480421

    申请日:2012-05-24

    CPC分类号: C07K14/70503 C07K2319/30

    摘要: This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention.

    摘要翻译: 本发明提供了包含ILT3的全部或部分细胞外结构域的第一多肽,其中多肽是水溶性的并且不包含免疫球蛋白的Fc部分。 本发明还提供了第二多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地附着于(ii)免疫球蛋白的Fc部分,其中所述免疫球蛋白的Fc部分包含功能增强突变,并且其中 该多肽是水溶性的。 本发明还提供了第三多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地固定于(ii)跨膜结构域。 本发明还提供了使用本发明的多肽的相关核酸,表达载体,宿主载体系统,组合物和制品以及治疗和预防方法。

    Ilt3 Polypeptides and Uses Thereof
    6.
    发明申请
    Ilt3 Polypeptides and Uses Thereof 有权
    Ilt3多肽及其用途

    公开(公告)号:US20080311073A1

    公开(公告)日:2008-12-18

    申请号:US11661877

    申请日:2005-09-01

    CPC分类号: C07K14/70503 C07K2319/30

    摘要: This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention.

    摘要翻译: 本发明提供了包含ILT3的全部或部分细胞外结构域的第一多肽,其中多肽是水溶性的并且不包含免疫球蛋白的Fc部分。 本发明还提供了第二多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地附着于(ii)免疫球蛋白的Fc部分,其中所述免疫球蛋白的Fc部分包含功能增强突变,并且其中 该多肽是水溶性的。 本发明还提供了第三多肽,其包含(i)ILT3的全部或部分细胞外结构域可操作地固定于(ii)跨膜结构域。 本发明还提供了使用本发明的多肽的相关核酸,表达载体,宿主载体系统,组合物和制品以及治疗和预防方法。